Global Patent Index - EP 1044004 A1

EP 1044004 A1 2000-10-18 - A2A ADENOSINE RECEPTOR AGONISTS IN COMBINATION WITH A TYPE IV PHOSPHODIESTERASE INHIBITORS

Title (en)

A2A ADENOSINE RECEPTOR AGONISTS IN COMBINATION WITH A TYPE IV PHOSPHODIESTERASE INHIBITORS

Title (de)

A2A ADENOSIN REZEPTOR AGONISTEN IN KOMBINATION MIT TYP IV PHOSPHODIESTERASE INHIBITOREN

Title (fr)

AGONISTES DE RECEPTEUR D'ADENOSINE A 2A?

Publication

EP 1044004 A1 (EN)

Application

EP 99901368 A

Priority

  • US 9900366 W
  • US 393098 A

Abstract (en)

[origin: WO9934804A1] Agonists of A2A adenosine receptors in combination with rolipram, its derivatives or other Type IV phosphodiesterase (PDE) inhibitors are effective for the treatment of inflammatory diseases.

IPC 1-7 (main, further and additional classification)

A61K 31/52

IPC 8 full level (invention and additional information)

C07H 19/167 (2006.01); A61K 31/52 (2006.01); A61K 31/7042 (2006.01); A61K 31/7052 (2006.01); A61K 31/7076 (2006.01); A61K 35/76 (2006.01); A61K 45/06 (2006.01); A61K 48/00 (2006.01); A61P 29/00 (2006.01); A61P 43/00 (2006.01)

CPC (invention and additional information)

A61K 31/52 (2013.01); A61K 45/06 (2013.01)

Combination set (CPC)

  1. A61K 45/06 + A61K 31/70 + A61K 31/40
  2. A61K 31/52 + A61K 31/40
  3. A61K 31/52 + A61K 2300/00

Citation (search report)

See references of WO 9934804A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9934804 A1 19990715; AU 2108299 A 19990726; CA 2317093 A1 19990715; EP 1044004 A1 20001018; JP 2002500188 A 20020108

INPADOC legal status


2003-06-11 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20021211

2002-09-18 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20020731

2000-10-18 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20000808

2000-10-18 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE